{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:32:35Z","timestamp":1783524755982,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017954","name":"Fujian Provincial Finance Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017954","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20419"],"award-info":[{"award-number":["U23A20419"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,470,173"],"award-info":[{"award-number":["82,470,173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.tranon.2025.102567","type":"journal-article","created":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T11:46:46Z","timestamp":1760874406000},"page":"102567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Longitudinal serum metabolomics predicts therapeutic outcome in acute myeloid leukemia"],"prefix":"10.1016","volume":"62","author":[{"given":"Qing","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianda","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2025.102567_bib0001","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global burden of hematologic malignancies and evolution patterns over the past 30 years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.tranon.2025.102567_bib0002","doi-asserted-by":"crossref","DOI":"10.1177\/2040620719827310","article-title":"Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia","volume":"10","author":"Short","year":"2019","journal-title":"Ther. Adv. Hematol."},{"issue":"7","key":"10.1016\/j.tranon.2025.102567_bib0003","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s12276-023-01020-1","article-title":"Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential","volume":"55","author":"Xu","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.tranon.2025.102567_bib0004","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Martinez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2025.102567_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","article-title":"Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression","volume":"73","author":"Li","year":"2016","journal-title":"Cell Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.tranon.2025.102567_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/cells8090967","article-title":"Targeting Metabolic Reprogramming in Acute Myeloid Leukemia","volume":"8","author":"Castro","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.tranon.2025.102567_bib0007","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1667\/RR0958.1","article-title":"Metabolomics using 1H-NMR of apoptosis and Necrosis in HL60 leukemia cells: differences between the two types of cell death and independence from the stimulus of apoptosis used","volume":"169","author":"Rainaldi","year":"2008","journal-title":"Radiat. Res."},{"issue":"13","key":"10.1016\/j.tranon.2025.102567_bib0008","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood.2024025245","article-title":"alpha-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia","volume":"145","author":"Millman","year":"2025","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.tranon.2025.102567_bib0009","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/leu.2017.45","article-title":"ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition","volume":"31","author":"Ju","year":"2017","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.tranon.2025.102567_bib0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.canlet.2016.04.040","article-title":"Metabolic alterations and drug sensitivity of tyrosine kinase inhibitor resistant leukemia cells with a FLT3\/ITD mutation","volume":"377","author":"Huang","year":"2016","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.tranon.2025.102567_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48970-0","article-title":"Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy","volume":"13","author":"Bolkun","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2025.102567_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1235160","article-title":"Untargeted metabolomic and lipidomic analyses reveal lipid dysregulation in the plasma of acute leukemia patients","volume":"10","author":"Arevalo","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"12","key":"10.1016\/j.tranon.2025.102567_bib0013","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41408-022-00764-9","article-title":"Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation","volume":"12","author":"Jentzsch","year":"2022","journal-title":"Blood Cancer J."},{"issue":"24","key":"10.1016\/j.tranon.2025.102567_bib0014","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102567_bib0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13059-021-02540-7","article-title":"Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects","volume":"22","author":"Dempster","year":"2021","journal-title":"Genome Biol."},{"issue":"11","key":"10.1016\/j.tranon.2025.102567_bib0016","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.chembiol.2006.09.009","article-title":"Pseudouridine synthases","volume":"13","author":"Hamma","year":"2006","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102567_bib0017","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7150\/ijbs.29203","article-title":"PSPH mediates the metastasis and proliferation of non-small cell lung cancer through MAPK signaling pathways","volume":"15","author":"Liao","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2025.102567_bib0018","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/gutjnl-2018-317065","article-title":"Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets","volume":"69","author":"Verrier","year":"2020","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.tranon.2025.102567_bib0019","article-title":"A tailored strategy to crosslink the aspartate transcarbamoylase domain of the multienzymatic protein CAD","volume":"28","author":"Del","year":"2023","journal-title":"Molecules."},{"issue":"38","key":"10.1016\/j.tranon.2025.102567_bib0020","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.2174\/0929867331666230712113943","article-title":"1,3,4-oxadiazole: an emerging scaffold to inhibit the thymidine phosphorylase as an anticancer agent","volume":"31","author":"Murmu","year":"2024","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.tranon.2025.102567_bib0021","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","article-title":"'Acute myeloid leukemia: a comprehensive review and 2016 update'","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J."},{"issue":"2","key":"10.1016\/j.tranon.2025.102567_bib0022","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood.2019001239","article-title":"How I treat acute myeloid leukemia in the era of new drugs","volume":"135","author":"DiNardo","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.tranon.2025.102567_bib0023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","article-title":"Emerging agents and regimens for AML","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102567_bib0024","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"issue":"47","key":"10.1016\/j.tranon.2025.102567_bib0025","doi-asserted-by":"crossref","first-page":"36267","DOI":"10.1074\/jbc.M110.141606","article-title":"Myc-dependent mitochondrial generation of acetyl-CoA contributes to fatty acid biosynthesis and histone acetylation during cell cycle entry","volume":"285","author":"Morrish","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.tranon.2025.102567_bib0026","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.tranon.2025.102567_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41375-021-01416-w","article-title":"Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia","volume":"36","author":"de Beauchamp","year":"2022","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.tranon.2025.102567_bib0028","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An inhibitor of oxidative phosphorylation exploits cancer vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.tranon.2025.102567_bib0029","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ccell.2018.08.016","article-title":"Subversion of systemic glucose metabolism as a mechanism to support the growth of leukemia cells","volume":"34","author":"Ye","year":"2018","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.tranon.2025.102567_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10110427","article-title":"Profiling of metabolic differences between hematopoietic stem cells and acute\/chronic myeloid leukemia","volume":"10","author":"Song","year":"2020","journal-title":"Metabolites."},{"issue":"1","key":"10.1016\/j.tranon.2025.102567_bib0031","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.urolonc.2020.06.026","article-title":"Pseudouridine as a novel biomarker in prostate cancer","volume":"39","author":"Stockert","year":"2021","journal-title":"Urol. Oncol."},{"issue":"8049","key":"10.1016\/j.tranon.2025.102567_bib0032","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-024-08335-7","article-title":"Aspartate signalling drives lung metastasis via alternative translation","volume":"638","author":"Doglioni","year":"2025","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.tranon.2025.102567_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165841","article-title":"Reprogramming of serine, glycine and one-carbon metabolism in cancer","volume":"1866","author":"Li","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis. Dis."},{"issue":"11","key":"10.1016\/j.tranon.2025.102567_bib0034","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s41423-022-00925-7","article-title":"Serine metabolism orchestrates macrophage polarization by regulating the IGF1-p38 axis","volume":"19","author":"Shan","year":"2022","journal-title":"Cell Mol. Immunol."},{"issue":"8","key":"10.1016\/j.tranon.2025.102567_bib0035","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1016\/j.apsb.2024.04.021","article-title":"Phenylalanine deprivation inhibits multiple myeloma progression by perturbing endoplasmic reticulum homeostasis","volume":"14","author":"Cheng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"7962","key":"10.1016\/j.tranon.2025.102567_bib0036","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41586-023-06061-0","article-title":"Lysine catabolism reprograms tumour immunity through histone crotonylation","volume":"617","author":"Yuan","year":"2023","journal-title":"Nature"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325002980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325002980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:32:33Z","timestamp":1773811953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325002980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":36,"alternative-id":["S1936523325002980"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102567","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal serum metabolomics predicts therapeutic outcome in acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102567"}}